Logo image of LIEN

CHICAGO ATLANTIC BDC INC (LIEN) Stock Fundamental Analysis

USA - NASDAQ:LIEN - US8281741020 - Common Stock

10.5 USD
-0.48 (-4.37%)
Last: 9/30/2025, 8:15:27 PM
Fundamental Rating

5

Taking everything into account, LIEN scores 5 out of 10 in our fundamental rating. LIEN was compared to 237 industry peers in the Capital Markets industry. LIEN has an excellent financial health rating, but there are some minor concerns on its profitability. LIEN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

LIEN had positive earnings in the past year.
LIEN had a negative operating cash flow in the past year.
LIEN Yearly Net Income VS EBIT VS OCF VS FCFLIEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M 10M

1.2 Ratios

LIEN has a Return On Assets of 5.33%. This is in the better half of the industry: LIEN outperforms 73.00% of its industry peers.
With a Return On Equity value of 5.55%, LIEN is not doing good in the industry: 60.34% of the companies in the same industry are doing better.
LIEN's Return On Invested Capital of 5.35% is fine compared to the rest of the industry. LIEN outperforms 69.62% of its industry peers.
Industry RankSector Rank
ROA 5.33%
ROE 5.55%
ROIC 5.35%
ROA(3y)3.58%
ROA(5y)N/A
ROE(3y)3.7%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LIEN Yearly ROA, ROE, ROICLIEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 50 -50

1.3 Margins

LIEN has a Profit Margin of 54.23%. This is amongst the best in the industry. LIEN outperforms 94.94% of its industry peers.
LIEN's Operating Margin of 66.22% is amongst the best of the industry. LIEN outperforms 98.31% of its industry peers.
LIEN has a better Gross Margin (77.36%) than 83.97% of its industry peers.
Industry RankSector Rank
OM 66.22%
PM (TTM) 54.23%
GM 77.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LIEN Yearly Profit, Operating, Gross MarginsLIEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

7

2. Health

2.1 Basic Checks

LIEN has more shares outstanding than it did 1 year ago.
LIEN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LIEN Yearly Shares OutstandingLIEN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
LIEN Yearly Total Debt VS Total AssetsLIEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 12.20 indicates that LIEN is not in any danger for bankruptcy at the moment.
LIEN has a Altman-Z score of 12.20. This is amongst the best in the industry. LIEN outperforms 95.78% of its industry peers.
There is no outstanding debt for LIEN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 12.2
ROIC/WACCN/A
WACCN/A
LIEN Yearly LT Debt VS Equity VS FCFLIEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

LIEN has a Current Ratio of 1.96. This is a normal value and indicates that LIEN is financially healthy and should not expect problems in meeting its short term obligations.
LIEN has a Current ratio of 1.96. This is in the better half of the industry: LIEN outperforms 70.04% of its industry peers.
LIEN has a Quick Ratio of 1.96. This is a normal value and indicates that LIEN is financially healthy and should not expect problems in meeting its short term obligations.
LIEN has a better Quick ratio (1.96) than 70.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.96
LIEN Yearly Current Assets VS Current LiabilitesLIEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1412.33% over the past year.
LIEN shows a strong growth in Revenue. In the last year, the Revenue has grown by 119229.00%.
EPS 1Y (TTM)1412.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)119229%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%324.5%

3.2 Future

LIEN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.11% yearly.
Based on estimates for the next years, LIEN will show a very strong growth in Revenue. The Revenue will grow by 76.50% on average per year.
EPS Next Y-27.55%
EPS Next 2Y15.94%
EPS Next 3Y13.11%
EPS Next 5YN/A
Revenue Next Year72.4%
Revenue Next 2Y116.15%
Revenue Next 3Y76.5%
Revenue Next 5YN/A

3.3 Evolution

LIEN Yearly Revenue VS EstimatesLIEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 20M 40M 60M
LIEN Yearly EPS VS EstimatesLIEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.19 indicates a reasonable valuation of LIEN.
69.62% of the companies in the same industry are more expensive than LIEN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.76, LIEN is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 7.30, the valuation of LIEN can be described as very cheap.
Based on the Price/Forward Earnings ratio, LIEN is valued cheaply inside the industry as 86.92% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.18, LIEN is valued rather cheaply.
Industry RankSector Rank
PE 10.19
Fwd PE 7.3
LIEN Price Earnings VS Forward Price EarningsLIEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LIEN Per share dataLIEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as LIEN's earnings are expected to grow with 13.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.94%
EPS Next 3Y13.11%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 12.27%, LIEN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 8.30, LIEN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.41, LIEN pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.27%

5.2 History

LIEN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
LIEN Yearly Dividends per shareLIEN Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

65.00% of the earnings are spent on dividend by LIEN. This is not a sustainable payout ratio.
DP65%
EPS Next 2Y15.94%
EPS Next 3Y13.11%
LIEN Yearly Income VS Free CF VS DividendLIEN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 5M -5M 10M
LIEN Dividend Payout.LIEN Dividend Payout, showing the Payout Ratio.LIEN Dividend Payout.PayoutRetained Earnings

CHICAGO ATLANTIC BDC INC

NASDAQ:LIEN (9/30/2025, 8:15:27 PM)

10.5

-0.48 (-4.37%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-05 2025-11-05/amc
Inst Owners26.74%
Inst Owner ChangeN/A
Ins Owners0.34%
Ins Owner Change0.07%
Market Cap239.61M
Analysts80
Price Target12.38 (17.9%)
Short Float %0.01%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield 12.27%
Yearly Dividend0.86
Dividend Growth(5Y)N/A
DP65%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-29 2025-09-29 (0.34)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.93%
Min EPS beat(2)7.53%
Max EPS beat(2)18.32%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.83%
Min Revenue beat(2)0.94%
Max Revenue beat(2)12.73%
Revenue beat(4)4
Avg Revenue beat(4)28.82%
Min Revenue beat(4)0.94%
Max Revenue beat(4)53.37%
Revenue beat(8)8
Avg Revenue beat(8)18.11%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.78%
Valuation
Industry RankSector Rank
PE 10.19
Fwd PE 7.3
P/S 7.77
P/FCF N/A
P/OCF N/A
P/B 0.8
P/tB 0.8
EV/EBITDA N/A
EPS(TTM)1.03
EY9.81%
EPS(NY)1.44
Fwd EY13.7%
FCF(TTM)-0.63
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS1.35
BVpS13.19
TBVpS13.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.33%
ROE 5.55%
ROCE 6.78%
ROIC 5.35%
ROICexc 5.63%
ROICexgc 5.63%
OM 66.22%
PM (TTM) 54.23%
GM 77.36%
FCFM N/A
ROA(3y)3.58%
ROA(5y)N/A
ROE(3y)3.7%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.96
Quick Ratio 1.96
Altman-Z 12.2
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1412.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-27.55%
EPS Next 2Y15.94%
EPS Next 3Y13.11%
EPS Next 5YN/A
Revenue 1Y (TTM)119229%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%324.5%
Revenue Next Year72.4%
Revenue Next 2Y116.15%
Revenue Next 3Y76.5%
Revenue Next 5YN/A
EBIT growth 1Y155.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-187.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-187.57%
OCF growth 3YN/A
OCF growth 5YN/A